Stem Cell Therapeutic and Research Reauthorization Act of 2025
House: Reported
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
Sign in to view Hilltelligence’s plain-English summary.
Action Timeline
- HouseLatest
Ordered to be Reported (Amended) by the Yeas and Nays: 48 - 0.
- House
Committee Consideration and Mark-up Session Held
- House
Forwarded by Subcommittee to Full Committee by Voice Vote.
- House
Subcommittee Consideration and Mark-up Session Held
- House
Referred to the Subcommittee on Health.
- House
Referred to the House Committee on Energy and Commerce.
- House
Introduced in House
Sign in to view Hilltelligence’s passage-probability analysis.
Official Sources
Topics
Policy area
Legislative subjects
Biological and life sciencesBlood and blood diseasesCell biology and embryologyHealth programs administration and fundingOrgan and tissue donation and transplantation
Sign in to view Hilltelligence’s potential-cosponsor analysis.